Latest inventory for VIRX: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2024), VIRX shows a inventory of $0. That compares with $-300K in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VIRX's inventory is now $0 (was $-300K) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Viracta Therapeutics is outperforming or lagging.
Tracking VIRX's inventory over time shows whether Viracta Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $-300K in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has Viracta Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.
Viracta Therapeutics's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.